XML 20 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Interim Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Dec. 31, 2016
Current assets:      
Cash and cash equivalents $ 6,673 $ 10,787 $ 2,709
Restricted cash 27 27
Other current assets 148 116 606
Total current assets 6,848 10,930 3,315
Fixed assets, net 280 90 53
Total assets 7,128 11,020 3,368
Current liabilities:      
Trade payables 194 78 512
Accrued liabilities 363 450 271
Total current liabilities 557 528 783
Long-term liabilities:      
Convertible notes 76
Derivative warrant liability 5 28 313
Total long term liabilities 28 389
Total liabilities 562 556 1,172
Commitments and contingencies    
Temporary equity:      
Common stock of $0.01 par value; issued and outstanding: 721,107 shares as of June 30, 2018 and December 31, 2017 and December 31, 2016 500 500 500
Shareholders' equity:      
Preferred stock of $0.01 par value; Authorized: 1,000,000 shares as of September 30, 2018 and December 31, 2017 and December 31, 2016; issued and outstanding: 550 and 4,001 and 9,736 shares as of September 30, 2018 and December 31, 2017 and December 31, 2016, respectively [1]
Common stock of $0.01 par value; Authorized: 220,000,000 as of September 30, 2018 and December 31, 2017 and December 31, 2016; issued and outstanding: 2,254,569 and 2,013,193 and 1,067,777 shares as of September 30, 2018, and December 31, 2017 and December 31, 2016, respectively 30 27 18
Additional paid-in capital 31,771 30,561 14,713
Accumulated deficit (25,735) (20,624) (13,035)
Total shareholders' equity 6,066 9,964 1,696
Total liabilities and shareholders' equity $ 7,128 $ 11,020 $ 3,368
[1] Less than 1